832
Synthesis of Novel Room Temperature Chiral Ionic Liquids
J. Braz. Chem. Soc.
705 (thin film); 1H NMR (300 MHz, CDCl3) d 7.98 (s, 1H),
7.46-7.26 (m, 5H), 4.76 (q, J 6.8 Hz, 1H), 3.96-3.81 (m, 2H),
3.80-3.68 (m, 2H), 3.50 (t, J 7.6 Hz, 2H), 1.72 (d, J 6.9 Hz,
3H), 1.69-1.59 (m, 2H), 1.40-1.21 (m, 4H), 0.89 (t, J 6.9 Hz,
3H);13C NMR (75 MHz, CDCl3) d 155.2 (CH), 137.4 (C0),
129.3 (CH), 128.9 (CH), 126.7 (CH), 58.2 (CH), 48.5 (CH2),
47.9 (CH2), 46.8 (CH2), 28.3 (CH2), 26.7 (CH2), 22.0 (CH2),
19.1 (CH3), 13.7 (CH3); MS (ESI +) m/z: 245 [M+]; MS
(ESI–)m/z:145[PF6–];HRMS(ESI+)m/z:CalcdforC16H25N2
[M+] 245.2018, found 245.2028; HRMS (ESI +) m/z: Calcd
for PF6 [PF6–] 144.9642, found 144.9635.
iodomethane (120 μL, 1.30 mmol, 1.35 equiv.) in acetonitrile
(2.0mL)wasstirredatroomtemperaturefor20h.Thesolution
was concentrated to dryness to give 16 (300 mg, quant.) as
a light yellow oil. [a]25 +4.3 (c 5.3, CHCl3); IR nmax/cm-1:
D
3120, 2934, 1604, 1572, 1496, 1330, 1156, 721 (thin film);
1H NMR (300 MHz, CDCl3) d 10.19 (s, 1H), 7.57 (t, J 1.7
Hz, 1H), 7.51-7.37 (m, 5H), 7.34 (t, J 1.8 Hz, 1H), 5.89 (q,
J 7.0 Hz, 1H), 4.14 (s, 3H), 2.06 (d, J 7.0 Hz, 3H);13C NMR
(75 MHz, CDCl3) d 137.5 (CH), 135.9 (C0), 129.3 (CH),
126.9 (CH), 123.8 (CH), 120.8 (CH), 59.9 (CH), 37.1 (CH3),
21.4 (CH3); MS (ESI +) m/z: 187 [M+]; MS (ESI –) m/z: 127
[I–]; HRMS (ESI +) m/z: Calcd for C12H15N2 [M+] 187.1235,
found 187.1237.
3-Pentyl-1-((1S)-1-phenylethyl)-4,5-dihydro-1H-imidazolium
bis(trifluoromethanesulfonyl)imide (13)
Prepared from imidazolinium bromide 11 (1.80 g,
5.54 mmol) according to the general procedure for the anion
metathesis with lithium bis(trifluoromethanesulfonyl)imide.
Salt 13 (2.32 g, 80%) was obtained as a light yellow liquid.
3-(3-cyanopropyl)-1-((1S)-1-phenylethyl)-1H-imidazolium
chloride (17)
Preparedfromimidazole14(1.04g,6.03mmol)according
to the general procedure for quaternarization in acetonitrile.
Chloride 17 (1.66 g, quant.) was obtained as light yellow oil.
[a]25D –1.2 (c 1.07, CHCl3); IR nmax/cm-1: 3057, 2938, 2467,
2247, 1558, 1496, 1456, 1258, 1158, 1014, 878, 853, 753,
706, 660 (thin film); 1H NMR (300 MHz, CDCl3) d 10.68 (s,
1H), 7.82 (s, 1H), 7.27-7.21 (m, 5H), 7.15 (s, 1H), 5.68 (q,
J 6.9 Hz, 1H), 4.57 (t, J 6.7 Hz, 2H), 2.58 (t, J 6.9 Hz, 2H),
2.28 (quintet, J 6.7 Hz, 2H), 1.89 (d, J 6.9 Hz, 3H);13C NMR
(75 MHz, CDCl3) d 137.7 (CH), 129.3 (CH), 126.7 (CH),
123.0 (CH), 120.7 (CH), 118.6 (C0), 60.0 (CH), 48.3 (CH2),
26.1 (CH2), 21.1 (CH3), 14.4 (CH2); MS (ESI +) m/z: 240
[M+]; HRMS (ESI +)m/z: Calcd for C15H18N3 [M+] 240.1501,
found 240.1481.
[a]25 –2.7 (c 1.49, CHCl3); Tg –59 °C; IR nmax/cm-1: 2961,
D
1649, 1456, 1350, 1186, 1136, 1056, 788, 739, 703 (thin film);
1HNMR(300MHz, CDCl3)d8.05(s, 1H), 7.46-7.34(m, 3H),
7.32-7.27 (m, 2H), 4.80 (q, J 7.0 Hz, 1H), 3.96-3.84 (m, 2H),
3.82-3.70(m,2H),3.48(t,J7.6Hz,2H),1.71(d,J6.9Hz,3H),
1.68-1.58(m,2H),1.39-1.20(m,4H),0.89(t,J7.0Hz,3H);13C
NMR(75MHz, CDCl3)d155.3(CH), 137.1(C0), 129.4(CH),
129.1(CH),126.7(CH),119.8(q,JC-F 321.3Hz,SO2CF3),58.2
(CH3), 48.6 (CH2), 48.0 (CH2), 46.7 (CH2), 28.3 (CH2), 26.8
(CH2),22.0(CH2),19.1(CH3),13.7(CH3);MSESI+)m/z:245
[M+]; MS (ESI –) m/z: 280 [NTf2–]; HRMS (ESI +) m/z: Calcd
for C16H25N2 245.2018 [M+], found 245.2029; HRMS (ESI –)
m/z: Calcd for C2NO4F6S2 279.9173 [NTf2–], found 279.9190.
3-Pentyl-1-((1S)-1-phenylethyl)-1H-imidazolium
bis(trifluoromethanesulfonyl)imide (18)
3-Pentyl-1-((1S)-1-phenylethyl)-1H-imidazoliumbromide(15)
Prepared from imidazole 14 (284 mg, 1.65 mmol)
according to the general procedure for quaternarization in
1,1,1-trichloroethane. Imidazolium 15 (530 mg, quant.) was
obtained as light brown liquid. [a]25D –13.2 (c 1.80, CHCl3);
IR nmax/cm-1: 3056, 2957, 2871, 1672, 1561, 1456, 1382,
1162, 732(thin film); 1H NMR (300 MHz, CDCl3) d 10.77
(s, 1H), 7.47-7.41 (m, 2H), 7.40-7.32 (m, 4H), 7.28-7.25 (m,
1H), 5.99 (q, J 7.0 Hz, 1H), 4.35 (t, J 7.4 Hz, 2H), 2.00 (d, J
7.4 Hz, 3H), 1.92 (quintet, J 7.4 Hz, 2H), 1.37-1.24 (m, 4H),
0.85 (t, J 7.0 Hz, 3H); 13C NMR (75 MHz, CDCl3) d 137.5
(CH), 135.1 (C0), 128.5 (CH), 128.4 (CH), 126.2 (CH), 121.9
(CH), 120.4 (CH), 58.9 (CH), 49.2 (CH2), 29.2 (CH2), 27.5
(CH2), 21.3 (CH2), 20.5 (CH3), 13.1 (CH3); MS (ESI +) m/z:
243 [M+]; MS (ESI –) m/z: 79, 81 [Br–]; HRMS (ESI +)m/z:
Calcd for C16H23N2 [M+] 243.1861, found 243.1865.
Prepared from imidazolium bromide 15 (909 mg,
2.81 mmol) according to the general procedure for the anion
metathesis with lithium bis(trifluoromethanesulfonyl)imide.
Salt 18 (1.30 g, 88%) was obtained as a light yellow liquid.
[a]25D –8.1 (c 1.73, CHCl3); Tg –57 °C; IR nmax/cm-1: 3146,
2962, 1557, 1557, 1457, 1349, 1186, 1136, 1055, 789, 704
1
(thin film); H NMR (300 MHz, CDCl3) d 8.87 (s, 1H),
7.46-7.37 (m, 3H), 7.36-7.32 (m, 2H), 7.31-7.28 (m, 1H),
7.25-7.22 (m, 1H), 5.67 (q, J 7.0 Hz, 1H), 4.18 (t, J 7.5 Hz,
2H), 1.95 (d, J 7.0 Hz, 3H), 1.86 (quintet, J 7.5 Hz, 2H),
1.42-1.22 (m, 4H), 0.88 (t, J 7.0 Hz, 3H);13C NMR (75 MHz,
CDCl3) d 137.5 (CH), 134.3 (C0), 129.5 (CH), 126.7 (CH),
122.5 (CH), 121.0 (CH), 119.8 (q, JC-F 321.4 Hz, SO2CF3),
60.1 (CH), 50.2 (CH2), 29.7 (CH2), 28.0 (CH2), 21.8 (CH2),
20.6 (CH3), 13.6 (CH3); MS (ESI +) m/z: 243 [M+]; MS
(ESI –) m/z: 280 [NTf2–]; HRMS (ESI +) m/z: Calcd for
C16H23N2 [M+] 243.1861, found 243.1865; HRMS (ESI –)
m/z:CalcdforC2NO4F6S2 [NTf2–]279.9173, found279.9170.
3-Methyl-1-((1S)-1-phenylethyl)-1H-imidazoliumiodide(16)
A solution of imidazole 14 (166 mg, 0.96 mmol) and